Condition
Cortical Visual Impairment
Total Trials
4
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed4
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07492966CompletedPrimary
Exosomes Effect on Visual Function in CVI
NCT06599996Not ApplicableCompleted
Artificial Intelligence and Augmentative and Alternative Communication AAC
NCT03957980Not ApplicableCompletedPrimary
Remote Access: Cortical Visual Impairment
NCT00342108Not ApplicableCompleted
Cortical Visual Impairment and Visual Attentiveness
Showing all 4 trials